P2RY12 and atrial fibrillation: If TAT (OAC, aspirin, and a P2Y12 inhibitor) is used for AF patients with PCI for ACS, a switch to DAT (OAC and a P2Y12 inhibitor) at 4–6 weeks may be a consideration” (9).